|
|
|
Volumn 315, Issue 7111, 1997, Pages 761-762
|
|
Determining prognosis after acute myocardial infarction in the thrombolytic era. Non-invasive investigations still have a place
|
|
Author keywords
[No Author keywords available]
|
|
Indexed keywords
ACETYLSALICYLIC ACID;
BETA ADRENERGIC RECEPTOR BLOCKING AGENT;
DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR;
FIBRINOLYTIC AGENT;
ACUTE HEART INFARCTION;
ANGIOCARDIOGRAPHY;
CORONARY ARTERY DISEASE;
COST EFFECTIVENESS ANALYSIS;
DIAGNOSTIC VALUE;
DISEASE SEVERITY;
EDITORIAL;
EXERCISE TEST;
HEART LEFT VENTRICLE FUNCTION;
HEART MUSCLE PERFUSION;
HEART MUSCLE REVASCULARIZATION;
HUMAN;
PRIORITY JOURNAL;
PROGNOSIS;
RISK ASSESSMENT;
CORONARY ANGIOGRAPHY;
EXERCISE TEST;
HUMANS;
MYOCARDIAL INFARCTION;
PROGNOSIS;
THROMBOLYTIC THERAPY;
|
|
EID: 0030810013
PISSN: 09598146
EISSN: None
Source Type: Journal
DOI: None Document Type: Editorial |
|
Times cited : (2)
|
|
References (13)
|
